The Pharmacy and Poisons Board (PPB) has warned Kenyans about a suspicious batch of falsified Avastin (Bevacizumab 100 mg) ...

Switzerland's Novartis and Roche were fined 444 million euros ($522 million) by France, after its competition authority said on Wednesday they used abusive practices to push costly eye injection ...

The Department of Veterans Affairs said it has stopped using the drug Avastin to treat eye disease, as it investigates concerns about serious infections and blindness from the drug, according to a ...

The Pharmacy and Poisons Board (PPB) has kick-started a crackdown on individuals and entities circulating a falsified batch ...

LONDON, June 11 (Reuters) - Roche's cancer drug Avastin is a cheap, effective treatment for preventing blindness and should be used routinely in countries that cannot afford the far more costly ...

One option for macular degeneration cuts treatment costs from $2,000 to $50. April 4, 2011— -- One drug costs $50 per dose. The other costs $2,000 per dose. Now, new research shows that the drug ...

Elderly people living on the Sunshine Coast who need eye injections in order to maintain their sight are having to pay out of ...

Due to a shortage of a widely used compounded medicine for serious eye diseases, two leading ophthalmologic groups want Medicare contractors to halt practices that limit coverage of other — albeit ...

CHICAGO, April 28 (Reuters) - Roche Holding AG's <ROG.VX> cancer drug Avastin works just as well as its far more expensive eye drug Lucentis in treating vision loss from macular degeneration, but has ...

Dear Dr. Roach: I was diagnosed with stage 1 bladder cancer in April. My urologist advised me to have BCG therapy for it. I just completed six weeks of the therapy. I also have macular degeneration in ...

The widely used cancer drug Avastin could save the eyesight of tens of thousands of people with age-related macular degeneration of the wet form, British researchers said Friday. The drug provides an ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. CHICAGO • A new analysis raises fresh questions about the risks of the blockbuster cancer drug Avastin, suggesting the chance of ...